Drug Recalls
Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.
Unexo Life Sciences Private Limited
cGMP Deviations
Unexo Life Sciences Private Limited
cGMP Deviations
Unexo Life Sciences Private Limited
cGMP Deviations
Unexo Life Sciences Private Limited
cGMP Deviations
Cipla USA, Inc.
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Cipla USA, Inc.
Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.
Lupin Pharmaceuticals Inc.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Lupin Pharmaceuticals Inc.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Lupin Pharmaceuticals Inc.
CGMP Deviations: Active pharmaceutical ingredient was sourced from an unapproved vendor
Dr. Reddy's Laboratories, Inc.
Failed Impurities/Degradation Specification
Dr. Reddy's Laboratories, Inc.
Failed Impurities/Degradation Specification
BLI International, Inc.
Superpotent Drug: Stability failure for assay at 6 months test time-point.
AvKARE
Labeling: Label Mix-Up
AvKARE
Labeling: Label Mix-Up
Elavil
Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…
Keystone Industries
Subpotent Drug
Apo-Amitriptyline
Product safety. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health con…
Akron Pharma, Inc.
CGMP Deviations
Jamp-Finasteride 5 mg tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Padagis US LLC
Subpotent and Superpotent Drug. Out of specification assay results recorded as part of Uniformity of Container test during long-term stability testing.
Stress-B-Plus Tablet
Product quality. Verify if your product is affected.Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health co…
Breckenridge Pharmaceutical, Inc
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
ACCORD HEALTHCARE, INC.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.